Wearable Injectors Market Size To Reach $23.89 Billion By 2030

Wearable Injectors Market Growth & Trends

The global wearable injectors market size is expected to reach USD 23.89 billion by 2030, expanding at a CAGR of 18.11 from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is expected to witness lucrative growth during the forecast period owing to technological advancements in wearable injectors coupled with rising demand for round-the-clock monitoring.

Technological advancements in wearable injectors, for instance, Bluetooth integrated wearable injectors, send alerts to patients, such as injection reminders and data regarding their therapy regime. Also, optional smart functionality provides connectivity to the healthcare network. Some of these devices have buttons that are accessible through clothing, and some devices prevent accidental activation. They also have audible and visual status indicators or signals. Patients can self-administer drugs subcutaneously with minimal time and effort as compared to intravenous or other routes. Patients don’t need to visit any healthcare provider for the administration.

The prevalence of lifestyle-associated diseases, such as diabetes and hypertension is expected to increase during the forecast period. These diseases demand round-the-clock monitoring of various physiological parameters, such as blood pressure and blood sugar levels. The advanced ecosystem of these devices helps healthcare care providers to access data from remote location, which reduces clinical decision time. Thus, integration of healthcare data with wearable injectors, which gets forwarded to physicians or doctors giving them real-time access to data with reduced errors, is expected to boost the wearable injectors market.

 Request a free sample copy or view report summary: Wearable Injectors Market Report

Wearable Injectors Market Report Highlights

• The on-body wearable injectors accounted for the largest revenue share in 2023 owing to the growing preference of the patients for adhesive patches that release the drug conveniently and can be worn on the skin

• The motor-driven segment is expected to register the highest growth during the forecast period owing to increasing demand from hospitals, clinics, retail chain stores, and pharmacies

• The oncology segment is expected to hold the largest market share due to the globally increasing incidences of cancer

• The home care segment is expected to dominate the market with the highest market share owing to increasing inclination towards the home-based treatments onset of Covid-19 pandemic can be seen and it has positively impacted the home care segment growth

• North America accounted for the largest revenue share of 33.2% in 2023. It is attributed to the rising prevalence of chronic & lifestyle-related diseases and augmented healthcare infrastructure.

Wearable Injectors Market Segmentation

Grand View Research has segmented the global wearable injectors market based on type, technology,application, end-use, and region:

Wearable Injectors Type Outlook (Revenue, USD Million, 2018 - 2030)

• On-body

• Off-body

Wearable Injectors Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Spring-based

• Motor-driven

• Rotary pump

• Expanding battery

• Other

Wearable Injectors Application Outlook (Revenue, USD Million, 2018 - 2030)

• Oncology

• Infectious disease

• Cardiovascular disease

• Autoimmune disease

• Immunodeficiency

• Others

Wearable Injectors End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Clinics

• Home care

• Others

Wearable Injectors Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

• U.S.

• Canada

• Europe

• UK

• Germany

• France

• Italy

• Spain

• Sweden

• Norway

• Denmark

• Asia Pacific

• China

• Japan

• India

• Australia

• Thailand

• South Korea

• Latin America

• Brazil

• Mexico

• Argentina

• Middle East & Africa

• Saudi Arabia

• South Africa

• UAE

• Kuwait

List of Key Players of Wearable Injectors Market

• BD

• Johnson & Johnson Services, Inc.

• F. Hoffmann-La Roche Ltd.

• Unilife Corporation

• Steady Med Therapeutics, Inc.

• Amgen Inc.

• Insulet Corporation

• Enable Injections

• West Pharmaceutical Services, Inc.

• CeQur Simplicity